Zhang, J.; Xu, R.; Lu, Q.; Xu, Z.; Liu, J.; Li, P.; Zhang, Y.; Zhou, C.; Luo, L.; Tang, W.;
et al. A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. Cancers 2023, 15, 615.
https://doi.org/10.3390/cancers15030615
AMA Style
Zhang J, Xu R, Lu Q, Xu Z, Liu J, Li P, Zhang Y, Zhou C, Luo L, Tang W,
et al. A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. Cancers. 2023; 15(3):615.
https://doi.org/10.3390/cancers15030615
Chicago/Turabian Style
Zhang, Junjie, Ran Xu, Qiang Lu, Zhenzhou Xu, Jianye Liu, Pei Li, Yaqun Zhang, Chuanchi Zhou, Lufeng Luo, Wei Tang,
and et al. 2023. "A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma" Cancers 15, no. 3: 615.
https://doi.org/10.3390/cancers15030615
APA Style
Zhang, J., Xu, R., Lu, Q., Xu, Z., Liu, J., Li, P., Zhang, Y., Zhou, C., Luo, L., Tang, W., Wang, Z., Cao, M., Cao, J., Xu, G., & Wang, L.
(2023). A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. Cancers, 15(3), 615.
https://doi.org/10.3390/cancers15030615